adr_usa_0531|APOP|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
adr_usa_0531|APOP|1|Cellect Biotechnology Ltd Total Current Assets (Quarterly) (USD)|Cellect Biotechnology Ltd Cash and Short Term Investments (Quarterly) (USD)|Cellect Biotechnology Ltd Inventories (Quarterly) (USD)|Cellect Biotechnology Ltd Net PP&E (Quarterly) (USD)|Cellect Biotechnology Ltd Goodwill and Intangibles (Quarterly) (USD)|Cellect Biotechnology Ltd Total Liabilities (Quarterly) (USD)|Cellect Biotechnology Ltd Total Current Liabilities (Quarterly) (USD)|Cellect Biotechnology Ltd Total Long Term Liabilities (Quarterly) (USD)|Cellect Biotechnology Ltd Total Deposits (Quarterly) (USD)|Cellect Biotechnology Ltd Book Value (Quarterly) (USD)|Cellect Biotechnology Ltd Retained Earnings (Quarterly) (USD)|Cellect Biotechnology Ltd Treasury Stock (Quarterly) (USD)|Cellect Biotechnology Ltd EV to Revenues|Cellect Biotechnology Ltd EV to Earnings|Cellect Biotechnology Ltd EV to Free Cash Flow|Cellect Biotechnology Ltd EV to Assets (Quarterly)|Cellect Biotechnology Ltd PS Ratio|Cellect Biotechnology Ltd PE Ratio|Cellect Biotechnology Ltd Price to Book Value|Cellect Biotechnology Ltd PEG Ratio|Cellect Biotechnology Ltd Debt to Equity Ratio|Cellect Biotechnology Ltd Dividend Yield|Cellect Biotechnology Ltd Shareholder Yield (TTM)|Cellect Biotechnology Ltd Percent of Shares Outstanding Short|Cellect Biotechnology Ltd Total Receivables (Quarterly) (USD)|Cellect Biotechnology Ltd Total Payables (Quarterly) (USD)|Cellect Biotechnology Ltd Total Capital Stock (Quarterly) (USD)|Cellect Biotechnology Ltd Return on Invested Capital|Cellect Biotechnology Ltd Quality Ratio Score|Cellect Biotechnology Ltd Momentum Score|Cellect Biotechnology Ltd Beta (1Y)|Cellect Biotechnology Ltd Sustainable Growth Rate (TTM)|Cellect Biotechnology Ltd Institutional Investor Ownership Percentage|Cellect Biotechnology Ltd Average Diluted Shares Outstanding (Quarterly)|Cellect Biotechnology Ltd Total Employees (Annual)|Cellect Biotechnology Ltd EPS Diluted (Quarterly) (USD)|Cellect Biotechnology Ltd Shares Outstanding|Cellect Biotechnology Ltd Repurchase of Capital Stock (Quarterly) (USD)|Cellect Biotechnology Ltd Ordinary Shares Number (Quarterly)|Cellect Biotechnology Ltd Payout Ratio|Cellect Biotechnology Ltd Quick Ratio (Quarterly)|Cellect Biotechnology Ltd Normalized Diluted EPS (Quarterly) (USD)|Cellect Biotechnology Ltd Stock Buybacks (Quarterly) (USD)|Cellect Biotechnology Ltd Effective Tax Rate (TTM)|Cellect Biotechnology Ltd Return on Equity|Cellect Biotechnology Ltd Net Income (TTM) (USD)|Cellect Biotechnology Ltd Revenue (TTM) (USD)|Cellect Biotechnology Ltd Dividend Per Share (Quarterly) (USD)|Cellect Biotechnology Ltd Revenue (Quarterly) (USD)|Cellect Biotechnology Ltd Gross Profit (Quarterly) (USD)|Cellect Biotechnology Ltd SG&A Expense (Quarterly) (USD)|Cellect Biotechnology Ltd Pre-Tax Income (Quarterly) (USD)|Cellect Biotechnology Ltd Net Income (Quarterly) (USD)|Cellect Biotechnology Ltd Net Interest Income (Quarterly) (USD)|Cellect Biotechnology Ltd Price (USD)|Cellect Biotechnology Ltd Total Return Price (USD)|Cellect Biotechnology Ltd Enterprise Value (USD)|Cellect Biotechnology Ltd 30-Day Average Daily Volume|Cellect Biotechnology Ltd 1 Year Price Returns (Daily)||
adr_usa_0531|APOP|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
adr_usa_0531|APOP|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|monthly|daily||
adr_usa_0531|APOP|5|96.6470588235|96.6470588235|0|96.6470588235|0|96.6470588235|96.6470588235|96.6470588235|0|96.6470588235|96.6470588235|96.6470588235|0|0|6.97989949749|0|0|0|7|0|0|1.44985941893|0|15.24|96.6470588235|96.6470588235|96.6470588235|0|0|31.2777777778|30.4473684211|0|30.6|91.35|365|91.35|41.8108108108|0|96.6470588235|0|0|91.35|91.2941176471|0|0|91.2941176471|0|0|0|0|91.35|91.35|91.35|91.35|6.96846846847|6.96846846847|6.96846846847|7|6.98224852071||
adr_usa_0531|APOP|6|17|17|0|17|0|17|17|17|0|17|17|17|0|0|199|0|0|0|221|0|0|1067|0|100|17|17|17|0|0|36|38|0|5|20|3|20|37|0|17|0|0|20|17|0|0|17|0|0|0|0|20|20|20|20|222|222|222|215|169||
adr_usa_0531|APOP|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
adr_usa_0531|APOP|201506||||||||||||||||||||||||||||||||||0.7911||-0.6982||||||-0.6982|||||||||0.1953|-0.5524|-0.5524|-0.0023|||||||
adr_usa_0531|APOP|201509||||||||||||||||||||||||||||||||||0.7911||-0.8313||||||-0.8313|||||||||0.2663|-0.6577|-0.6577|0.0039|||||||
adr_usa_0531|APOP|201512|3.1192|3.0135||0.3046||0.734|0.734|0||2.695|-5.236|2.4188|||||||||||||0.048|0.2382|0|||||||0.7911||-1.2034|||81.7373|||-1.2034|||||||||0.4741|-0.952|-0.952|-0.0077|||||||
adr_usa_0531|APOP|201603||||||||||||||||||||||||||||||||||0.8174||-1.1882||||||-1.1882|-1.9313|||-3.1333|||||0.4947|-0.9712|-0.9712|-0.0072|||||||
adr_usa_0531|APOP|201606|3.4497|3.029||0.3469||0.4617|0.4617|0||3.34|-7.1116|2.4488|||||||6.1121|||0||0|0.4207|0.4617|0|||||||0.8174||-1.0212|0.8174||81.7373|||-1.1111|-0.0278|||-3.4155|||||0.4244|-0.8347|-0.8347|0.0013|24.975|24.975|17.3855|||24.1|
adr_usa_0531|APOP|201609|9.7584|4.2082||0.362||1.6087|0.7822|0.8265||8.517|-8.7997|2.5162|||||||2.9052|||0||0.3563|0.3083|0.7822|0|||||||0.9849||-1.448|1.0758||107.5835|||-1.448|-7.2772|||-4.1969|||||0.7108|-1.439|-1.439|-0.1861|23|23|20.5352|12857.7||21.5|16.905
adr_usa_0531|APOP|201612|8.4478|2.9403||0.358||1.4141|0.9087|0.5054||7.4282|-9.3141|2.4577|||-3.3573||||1.9515|||0||0.1313|0.1726|0.3538|0|||||||1.0776|18|-0.7063|1.0758||107.5835|||-0.7063|0.1254|||-3.9988|||||0.4502|-0.7539|-0.7539|0.355|15.45|15.45|12.4129|3832.0333||15.9|30.7
adr_usa_0531|APOP|201703|7.5312|2.1631||0.3725||3.1144|0.7146|2.3998||4.8279|-13.2704|2.5964|||-13.618||||9.6263|||0||0.6709|0.4146|0.7146|0|||||||0.9115||-3.6763|1.0808||108.0835|||-3.6763|0|||-6.3687|||||0.684|-3.3411|-3.3411|-1.8999|54.5|54.5|55.7059|462564||40.5|46.15
adr_usa_0531|APOP|201706|6.691|1.2477||0.3744||2.8997|0.8194|2.0803||4.2874|-15.1402|2.704|||-9.5223||||9.0666|||0||2.2131|0.3173|0.8194|0|||9|8.4763|||1.2492||-0.5856|1.088||108.8045|||-0.5856|0|||-6.8174|||||0.9752|-1.2833|-1.2833|0.3625|40.5|40.5|41.6093|28783.0333|48.5485|37.75|39.85
adr_usa_0531|APOP|201709|9.5115|9.227||0.3598||4.0778|1.635|2.4428||5.9074|-17.1616|2.6703|||-9.4829||||10.7248|||0||1.7894|0.2844|0.9417|0|||9|7.0759|||1.1148||-1.9691|1.1984||119.8437|||-1.9691|-4.1894|||-7.5731|||||0.9784|-2.1947|-2.1947|-0.4084|40.55|40.55|43.041|47969.7|89.6396|44.1|41.5
adr_usa_0531|APOP|201712|8.2772|8.0401||0.3896||3.3401|1.1883|2.1517||5.4654|-18.5378|2.7324|||-6.4211||||7.2442|||0||1.3647|0.071|0.4972|0|||10|13.7281|||1.2031|24|-0.7988|1.2014||120.1407|||-0.7988|0.1786|||-7.7803|||||0.4405|-0.9611|-0.9611|0.9817|34.2|34.2|31.8266|32338.7667|130.2632|42|36.05
adr_usa_0531|APOP|201803|10.0989|9.8808||0.3998||2.9257|0.9171|2.0086||7.7533|-19.2663|2.6894|||-6.425||||7.5274|||0||1.3509|0.218|0.9171|0|||2|2.6913|||1.2697||-0.8097|1.3019||130.1928|||-0.8097|-3.5755|||-5.4729|||||0.9982|-1.0338|-1.0338|0.7906|31|31|32.3188|26597.5333|13.2239|34.05|36.4
adr_usa_0531|APOP|201806|8.458|7.2057||0.3752||2.9127|0.8199|2.0928||6.0533|-20.1167|2.5793|||-6.7563||||6.0198|||0||0.8674|0.2534|0.8199|25.9023|||2|2.7957|||1.3023||-1.2879|1.3019||130.1928|||-1.2879|0.1149|||-5.8664|||||1.0135|-1.6768|-1.6768|0.0342|35.75|35.75|36.6621|12237|-15.9437|33.495|27.25
adr_usa_0531|APOP|201809|6.6545|6.4899||0.461||2.7003|0.9444|1.7559||4.547|-22.2866|2.6157|||-4.1509||||5.2972|||0||0.7657|0.1646|0.9444|0|||2|2.4184|||1.3019||-1.433|1.3019||130.1928|||-1.433|0.0545|||-5.5451|||||1.0827|-1.8733|-1.8733|0.3461|24|24|24.0399|12729.7|-41.0766|23.7|16.7
adr_usa_0531|APOP|201812|4.95|4.7332||0.4104||1.7847|1.302|0.4826||3.7004|-22.3399|2.5049|||-1.4356||||3.579|||0||0.5063|0.0574|0.2878|0|||2|2.0677|||1.3029|28|-0.783|1.3041||130.4148|||-0.783|-0.0365|||-5.5967|||||0.7636|-1.0128|-1.0128|1.3559|11.8|11.8|8.8985|18619.1667|-64.9369|13.5|5.7
adr_usa_0531|APOP|201903|9.8259|9.6171||0.8455||4.7321|1.7975|2.9346||6.0651|-24.5959|2.6|||-0.2746||||1.7464|||0||1.5218|0.2088|1.6618|0|||1|1.3775|||1.7728||-0.7959|2.2409||224.0878|||-0.7959|-6.8165|||-5.9637|||||0.6463|-1.4008|-1.4008|0.2124|5.054|5.054|1.8578|102713.4667|-84.318|4.3255|3.375
adr_usa_0531|APOP|201906|7.8227|7.6294||0.776||2.5879|1.3028|1.2851||6.1351|-25.1967|2.6394|||0.6041||||0.8914|||0||0.0892|0.1932|1.1717|0|||1|0.7475||9.4016|2.2461||0|2.2409||224.0878|||0|0.2129|||-4.5138|||||0.7541|-0.2269|-0.2269|1.519|2.6|2.6|-4.2109|15876.5|-93.2706|3.445|2.5025
adr_usa_0531|APOP|201909|6.4791|6.278||0.7284||2.0251|0.9976|1.0275||5.3065|-27.2357|2.7081|||0.3051||||0.8611|||0||0.0218|0.2011|0.8747|0|||1|0.8776||4.5531|2.2409||-0.5961|2.2409||224.0878|||-0.5961|-0.1306|||-4.0064|||||0.7858|-1.366|-1.366|0.1195|2.425|2.425|-2.2078|29201.9|-90.177|2.47|2.38
adr_usa_0531|APOP|201912|5.3691|5.2336||0.6715||1.8739|1.0504|0.8235||4.2886|-29.1548|2.7243|||0.1692||||0.9502|||0||0.0847|0.0772|0.0971|0|||1|0.6583||1.1455|2.2426|14|-0.7733|2.2409||224.0878|||-0.7733|0.4459|||-4.734|||||0.352|-1.7403|-1.7403|-0.3228|2.2197|2.2197|-1.171|24190.7333|-81.768|2.37|2.2775
adr_usa_0531|APOP|202003|7.1892|7.0745||0.6079||1.7838|1.2491|0.5347||6.1302|-28.9969|2.6427|||0.0309||||1.2042|||0||0.6336|0.1147|1.1317|0|||2|0.8064|||3.2431||-0.2293|3.3753||337.5331|||-0.2293|-2.6148|||-4.0646|||||0.7415|-0.7315|-0.7315|0.4506|1.4979|1.4979|-0.1777|529334.5|-69.1504|2.47|2.92
adr_usa_0531|APOP|202006|7.3256|7.0469||0.5793||1.6954|0.8694|0.8261||6.3274|-32.5849|2.7367|||-0.8971||||1.9463|||0||0.3817|0.2788|0.7486|0|||5|3.1952|||3.5205||-0.7402|3.9095||390.9491|||-0.7402|-0.0025|||-6.3441|||||0.6024|-2.5063|-2.5063|-1.5156|3.29|3.29|4.0302|186492.2333|26.5385|3.22|2.44
adr_usa_0531|APOP|202009|||||||||||||||-0.6399||||1.3284|||0||2.3324||||||5|2.2108||||||3.9095||||||||||||||||||2.49|2.49|2.6878|163486.9667|2.6804|1.9489|